KHSC expands liver cancer treatment with cutting-edge Y90 therapy
Kingston Health Sciences Centre (KHSC) is now home to one of the most advanced treatments for liver cancer in Canada....
Month: May 2025
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment...
Neuralink rival Inbrain will ‘never’ take brain implants beyond healthcare
Elon Musk has outlandish plans for Neuralink’s brain-computer interfaces, from giving people “superpowers” to downloading their memories. Spanish rival Inbrain...
Hamilton hospital appeals for living donors as more than 100 people await life-saving kidney transplants
It's been 51 years since St. Joseph's Healthcare Hamilton carried out its first living donor kidney transplant. Since then, the hospital's...
Liver Cancer Treatment Market to Reach $12.88 Billion by 2033,
Liver Cancer Treatment MarketLiver Cancer Treatment Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market...
80 Nurses Rally to Save Baby Girl Who Needed Liver Transplant
Nine-month-old Mattie Beacham was in a coma; her organs were shutting down, and her little body was fighting a battle...
